Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TBCRC Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies (EVOLVE-BDT)

NCT07340541 is registered in ClinicalTrials.gov with UNC Lineberger Comprehensive Cancer Center as lead sponsor.

NCT NCT07340541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07340541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TBCRC Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies (EVOLVE-BDT)
Lead sponsor
UNC Lineberger Comprehensive Cancer Center
Phase
Phase 2
Overall status
Recruiting
Start date
February 16, 2026
Completion date
June 2, 2031
Enrollment
700 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, estrogen-receptor-positive breast cancer, hormone receptor negative breast carcinoma, metastatic breast cancer, triple negative breast cancer